TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14654535

Group type: EXPERIMENTAL
Intervention: IFN‐gamma (1.5 x 10(7) IU/instillation)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Mitomycin C (40 mg/instillation)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: IFN‐gamma
Number of subjects: 123
Study: 10838647

Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate vaccine (0.5 mL doses, groups 1 and 2; n=60 each)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Hepatitis B control vaccine (group 3; n=62)
Number of subjects: 182
Study: 10452046

Group type: EXPERIMENTAL
Intervention: Local delivery of drugs (prednisolone and procaine) during tissue expansion
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no local drug delivery)
Number of subjects: 34
Study: 1589555

Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl (THP) 2 mg, 4 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Biperiden (BPD) 1 mg, 2 mg, 5 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mazaticol (MZC) 4 mg, 8 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: L-dopa (LDP) 100 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bromocriptine (BMC) 1.25 mg, 2.5 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amantadine (AMD) 100 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amitriptyline (ATP) 25 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Haloperidol (HPD) 3 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diazepam (DZP) 3 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Inert placebo (PLB)
Number of subjects: 6
Study: 3896595

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg, b.d.)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 29746229

Group type: EXPERIMENTAL
Intervention: Intraperitoneal and intravenous paclitaxel plus S-1 (IP); intraperitoneal paclitaxel 20 mg/m2 and intravenous paclitaxel 50 mg/m2 on days 1 and 8 plus S-1 80 mg/m2 per day on days 1 to 14 for a 3-week cycle
Number of subjects: 183

Group type: COMPARATOR
Intervention: S-1 plus cisplatin (SP); S-1 80 mg/m2 per day on days 1 to 21 plus cisplatin 60 mg/m2 on day 8 for a 5-week cycle
Number of subjects: 183
Study: 26732017

Group type: EXPERIMENTAL
Intervention: Water-soluble cinnamon extract
Number of subjects: 428

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study: 24665241

Group type: EXPERIMENTAL
Intervention: I.V ramosetron 0.3 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: I.V Ondansetron 4 mg
Number of subjects: 60
Study: 23460233

Group type: EXPERIMENTAL
Intervention: Deferiprone monotherapy, average dose 79.1±4.3 mg/kg/day
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deferiprone monotherapy
Number of subjects: 73
Study: 20434760

Group type: EXPERIMENTAL
Intervention: Template circumcision
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard sleeve circumcision
Number of subjects: 30
Study: 18403668

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg qd
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg bid
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 15733983

Group type: EXPERIMENTAL
Intervention: Autologous serum eyedrops
Number of subjects: 20

Group type: COMPARATOR
Intervention: Preservative-free artificial tears
Number of subjects: 20
Study: 11854905

Group type: EXPERIMENTAL
Intervention: H. pylori infection
Number of subjects: 21
Study: 9648571

Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 2.0
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 3.0
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 4.0
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lactic acid 5% at pH 3.0
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lactic acid 15% at pH 3.0
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 26
Study: 7653685

Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Counseling plus supplemental drug counseling
Number of subjects: 84
Study: 2527224

Group type: EXPERIMENTAL
Intervention: Teicoplanin and netilmicin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Flucloxacillin and netilmicin
Number of subjects: 21
Study: 791192

Group type: EXPERIMENTAL
Intervention: BA‐34647 (experimental antispasticity drug)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31847158

Group type: EXPERIMENTAL
Intervention: Soft tissue therapy (additional therapy program alongside standard physical therapy)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard physical therapy (control group)
Number of subjects: 49
Study: 29454141

Group type: EXPERIMENTAL
Intervention: Enhanced Care worksite cessation program
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 126
Study: 27368000

Group type: EXPERIMENTAL
Intervention: Oral ketamine (5 mg/kg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral midazolam (0.7 mg/kg)
Number of subjects: 68
Study: 25144127

Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (150 μg/mL) in left eye, balanced salt solution in right eye (Group A)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (500 μg/mL in right eye, 150 μg/mL in left eye) (Group B)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (150-500 μg/mL)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Bag and chamber flushing technique
Number of subjects: 69
Study: 22124104

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus surgery (gemcitabine 1,250 mg/m² days 1 and 8 every 3 weeks plus cisplatin 75 mg/m² day 1 every 3 weeks followed by surgery)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus surgery
Number of subjects: 270
Study: 18930374

Group type: EXPERIMENTAL
Intervention: Bedside ultrasound performed by emergency physicians
Number of subjects: 6
Study: 17488461

Group type: EXPERIMENTAL
Intervention: Retrobulbar anaesthesia (RBA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Topical anaesthesia (TA)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both methods of anaesthesia
Number of subjects: 115
Study: 15127220

Group type: EXPERIMENTAL
Intervention: Dynamic MRI (dMRI) in healthy volunteers
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Dynamic MRI (dMRI) in patients with a tumor in the lower lung region
Number of subjects: 43

Group type: COMPARATOR
Intervention: Dynamic MRI (dMRI) in patients with tumors of the upper and middle lung region
Number of subjects: 43
Study: 11897280

Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 9568220

Group type: EXPERIMENTAL
Intervention: Azathioprine and prednisone
Number of subjects: 3
Study: 7528662

Group type: EXPERIMENTAL
Intervention: Casodex 50 mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 2764059

Group type: COMPARATOR
Intervention: 6-week diet alone (24 to 30 kcal/kg/24 hours; 20% protein, 40% carbohydrate, 40% fat)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 6-week diet plus exercise (20 minutes three times a week for 6 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 6-week diet alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 6-week diet plus exercise
Number of subjects: 19
Study: 936381

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 125
Study: 31841026

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined treatment of dobutamine and terlipressin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31152372

Group type: EXPERIMENTAL
Intervention: 5 mL boluses of bupivacaine 0.125% with fentanyl 2 µg·mL-1
Number of subjects: 40
Study: 28666474

Group type: EXPERIMENTAL
Intervention: AN69ST hemofilter
Number of subjects: 60

Group type: COMPARATOR
Intervention: AN69 hemofilter
Number of subjects: 60
Study: 26095142

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 24125150

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol 80 μg
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol 160 μg
Number of subjects: 715

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study: 21466994

Group type: EXPERIMENTAL
Intervention: Ultrasonic cautery (UC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-frequency electrocautery (EC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both UC and EC
Number of subjects: 40
Study: 19683881

Group type: EXPERIMENTAL
Intervention: Artelon implant
Number of subjects: 53

Group type: COMPARATOR
Intervention: APL tendon suspension interposition arthroplasty
Number of subjects: 53
Study: 18184530

Group type: EXPERIMENTAL
Intervention: Basal Supported Oral Treatment (BOT) - insulin glargine combined with glimepiride and metformin
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Conventional Therapy (CT) - premixed insulin
Number of subjects: 10000
Study: 15056522

Group type: EXPERIMENTAL
Intervention: Subjects with schizophrenia
Number of subjects: 42

Group type: COMPARATOR
Intervention: Subjects with major depressive disorder
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison subjects with no psychiatric disorder
Number of subjects: 42
Study: 11588126

Group type: EXPERIMENTAL
Intervention: Case-managed approach using computerized tracking and universal colposcopy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 54
Study: 9413382

Group type: EXPERIMENTAL
Intervention: Javid shunt
Number of subjects: 163

Group type: COMPARATOR
Intervention: Pruitt shunt
Number of subjects: 163
Study: 1785707

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (5 micrograms.kg‐1 during the first hour, and 0.3 microgram.kg‐1.h‐1 thereafter)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine
Number of subjects: 50
Study: 7265042

Group type: EXPERIMENTAL
Intervention: Standard film taken during arterial time after contrast medium injection
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Zonography during arterial time in the plane of the arteries
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group with simple film taken during nephrographic time (arterial time + 10 seconds)
Number of subjects: 3
Study: 30578750

Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional rotatory technique
Number of subjects: 21
Study: 28422864

Group type: EXPERIMENTAL
Intervention: Ketamine (100, 200, 1000 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine (200 ng/mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 0
Study: 25482548

Group type: EXPERIMENTAL
Intervention: LISTERINE Antiseptic (LA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crest Pro‐Health Rinse (CPH)
Number of subjects: 0
Study: 24797262

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (nucleoside analogue)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment interruption
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment interruption in patients with low on-treatment levels of serum IFN‐γ
Number of subjects: 18
Study: 22633079

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Hypercaloric diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Eucaloric diet
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Energy intake and balance
Number of subjects: 55
Study: 20926321

Group type: EXPERIMENTAL
Intervention: Manual compression during UGFS
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Surgical ligation of the SF junction
Number of subjects: 8

Group type: COMPARATOR
Intervention: No compression during UGFS
Number of subjects: 8
Study: 18347895

Group type: EXPERIMENTAL
Intervention: TPB-based behavior change intervention (print materials alone or combined with a step pedometer)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Standard public health recommendation for PA (SR group)
Number of subjects: 377
Study: 15734776

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 12190751

Group type: EXPERIMENTAL
Intervention: Oral flumazenil
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 18
Study: 10597552

Group type: EXPERIMENTAL
Intervention: Propofol-N2O
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane-N2O
Number of subjects: 40
Study: 8813983

Group type: EXPERIMENTAL
Intervention: Conventional treatment with additional biofeedback training (CT+BF)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 192
Study: 1567626

Group type: EXPERIMENTAL
Intervention: Hyperkalemic cold cardioplegia and initial hyperkalemic reperfusion
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Noncardioplegic blood reperfusate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Randomized protocols with initial cardioplegic reperfusion
Number of subjects: 160

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 160
Study: 2861567

Group type: EXPERIMENTAL
Intervention: OKT3 monoclonal antibody treatment for acute rejection, daily for a mean of 14 days, with concomitant lowering of other immunosuppressive drugs.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Conventional high-dose steroids treatment for acute rejection.
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: OKT3 treatment group.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Conventional high-dose steroids treatment group.
Number of subjects: 123
Study: 31183443

Group type: EXPERIMENTAL
Intervention: Povidone-iodine applicator
Number of subjects: 498

Group type: COMPARATOR
Intervention: Conventional sterilization
Number of subjects: 498
Study: 30116110

Group type: EXPERIMENTAL
Intervention: RG (Plyometric Jump Training with randomization)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NRG (Plyometric Jump Training without randomization)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 27942206

Group type: EXPERIMENTAL
Intervention: Carers’ education and ultrasound baths for denture cleaning
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 219
Study: 25252490

Group type: EXPERIMENTAL
Intervention: Prostafit
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prostafit and Prazosin
Number of subjects: 100
Study: 22842057

Group type: EXPERIMENTAL
Intervention: Topical application of tranexamic acid (5 g in 100 ml saline solution)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (100 ml saline solution)
Number of subjects: 89
Study: 19948872

Group type: EXPERIMENTAL
Intervention: GFR <60 ml/min/1.73 m(2)
Number of subjects: 3851

Group type: EXPERIMENTAL
Intervention: GFR <60 ml/min/1.73 m(2) in women without pre-existing CVD
Number of subjects: 3851

Group type: EXPERIMENTAL
Intervention: Women with pre-existing CVD
Number of subjects: 3851
Study: 17627004

Group type: EXPERIMENTAL
Intervention: High fruit-vegetable diet
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combination low-fat/high fruit-vegetable diet
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 122
Study: 16096517

Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg/day)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 12474549

Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10454016

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study: 8645892

Group type: EXPERIMENTAL
Intervention: Moderate hydration plus ANP infusion (ANP group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Maximal hydration (MH) regimen (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ANP group
Number of subjects: 40
Study: 1698429

Group type: EXPERIMENTAL
Intervention: Iloprost (IL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Prostacyclin (PGI2)
Number of subjects: 12
Study: 7391323

Group type: EXPERIMENTAL
Intervention: Adrenosem salicylate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study: 31710601

Group type: EXPERIMENTAL
Intervention: Full oxygen system
Number of subjects: 24859

Group type: COMPARATOR
Intervention: Pulse oximetry
Number of subjects: 24859
Study: 28152170

Group type: EXPERIMENTAL
Intervention: Physical activity counseling intervention
Number of subjects: 398

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 398
Study: 26406467

Group type: EXPERIMENTAL
Intervention: Sustained lung inflations (SLI) - 1-3 SLI (30 cmH2O for 15 s) followed by respiratory standard care.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group - respiratory standard care only.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between SLI and Control groups.
Number of subjects: 40
Study: 24331773

Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural weight management programme
Number of subjects: 49
Study: 20835746

Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention
Number of subjects: 198
Study: 19965029

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 0
Study: 17258387

Group type: COMPARATOR
Intervention: Catheterized group (C) - polyurethane catheter (5F) passed through the ureter after lithotripsy, removed after 24h
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Noncatheterized group (NC) - no catheterization
Number of subjects: 140
Study: 15090934

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson disease and migraine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patients without migraine
Number of subjects: 28
Study: 11576102

Group type: EXPERIMENTAL
Intervention: Oral midazolam premedication
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9778067

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7871107

Group type: EXPERIMENTAL
Intervention: High cynical distrust and high anger-control
Number of subjects: 119

Group type: COMPARATOR
Intervention: Established biological risk factors (serum low-density lipoprotein cholesterol concentration, smoking, old age)
Number of subjects: 119
Study: 3175455

Group type: EXPERIMENTAL
Intervention: Single puff of 100 microliters volume
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Two puffs of 50 microliters
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Decreased spray cone angle from 60 degrees to 35 degrees
Number of subjects: 13
Study: 30094707

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radical R0 resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiochemotherapy and chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy
Number of subjects: 0
Study: 27038440

Group type: EXPERIMENTAL
Intervention: betamethasone valerate cream
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: roflumilast 0.5% cream
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TAK‐084 0.5% cream
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TAK‐084 5% cream
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: calcipotriol 0.005% cream
Number of subjects: 15

Group type: COMPARATOR
Intervention: vehicle cream
Number of subjects: 15
Study: 26177521

Group type: EXPERIMENTAL
Intervention: Family Health History (FHH) assessment
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control information
Number of subjects: 116
Study: 23601333

Group type: EXPERIMENTAL
Intervention: Probiotics (VSL#3, 900 billion/day)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Antibiotics (norfloxacin 400 mg BD)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Propranolol alone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Probiotics (VSL#3)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Antibiotics (norfloxacin)
Number of subjects: 94
Study: 20152700

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of dyssynchrony with epsilon-pl < -7.8%
Number of subjects: 40
Study: 19189671

Group type: EXPERIMENTAL
Intervention: XP‐Bond applied on collagen-depleted dentin (group 1)
Number of subjects: 2

Group type: COMPARATOR
Intervention: XP‐Bond applied in accordance with manufacturers' instructions (group 2)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: XP‐Bond applied on collagen-depleted dentin (group 1) after 6 months
Number of subjects: 2

Group type: COMPARATOR
Intervention: XP‐Bond applied in accordance with manufacturers' instructions (group 2) after 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Interfacial nanoleakage expression along XP‐Bond adhesive interfaces
Number of subjects: 2
Study: 15708298

Group type: EXPERIMENTAL
Intervention: D‐cycloserine (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 12
Study: 12902095

Group type: EXPERIMENTAL
Intervention: Embol-X intraaortic filter
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Control (nonfiltered)
Number of subjects: 1289
Study: 10566920

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.125%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 50